Gnai3-flox Mouse

Gnai3, also known as Guanine nucleotide binding protein, alpha inhibiting activity polypeptide 3, is involved in multiple biological processes. It plays roles in signal transduction pathways, such as those related to G-protein coupled receptors. Inhibitory G proteins like Gnai3 are crucial in regulating various cellular functions, including cell growth, differentiation, and inflammation [5,6,7,8,9]. Genetic models, like the Gnai3-iresGFP reporter mouse line, are valuable tools for studying Gnai3 expression patterns [3].

In a mouse model, GNAI1 and GNAI3 double-knockout (DKO) mice showed more severe colitis and significantly more colonic tumors compared to control mice. This indicates that GNAI3 suppresses DSS-plus-AOM-induced colon tumor development, possibly by blocking IL6 signaling and down-regulating GNAI2 expression [2]. In hepatocellular carcinoma (HCC), down-regulation of GNAI3 by miR-222 promoted cell migration and invasion, and low GNAI3 expression predicted poor prognosis in HCC patients [4,8]. In non-alcoholic fatty liver disease (NAFLD) mouse and cell models, GNAI3 knockout enhanced dysregulated hepatic lipid metabolism and liver damage, suggesting GNAI3 is a potential target for NAFLD treatment [6]. In periodontal stem cells, GNAI3, mediated by Lin28A, regulated lipopolysaccharide-induced inflammation and osteogenic differentiation via the NF-κB/NLRP3 inflammasome pathway [1]. Also, in osteoblast precursor cells, Gnai3 regulated cell proliferation, migration, osteogenic differentiation, and mineralization through the MAPK signaling pathway, and its mutation was related to congenital small jaw deformity [9].

In conclusion, Gnai3 is essential in regulating multiple biological processes. Model-based research, especially gene knockout mouse models, has revealed its significant roles in various disease areas, including colon cancer, HCC, NAFLD, periodontitis, and congenital mandibular defects. These findings provide potential therapeutic targets and a better understanding of the underlying disease mechanisms related to Gnai3.